Research on the advantages and disadvantages and the challenges of mRNA vaccines: taking the COVID-19 mRNA vaccine as an example

Chenyuan Ji

doi:10.1117/12.2692432

7 September 2023 Research on the advantages and disadvantages and the challenges of mRNA vaccines: taking the COVID-19 mRNA vaccine as an example

Chenyuan Ji

Author Affiliations +

Proceedings Volume 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023); 1278931 (2023) https://doi.org/10.1117/12.2692432
Event: International Conference on Modern Medicine and Global Health (ICMMGH 2023), 2023, Oxford, United Kingdom

Abstract

Since the outbreak of the COVID-19 pandemic in 2020, the medical system of many countries has been gradually defeated. COVID-19 The virus exists all the time and everywhere. There is a "new normalcy" that the novel coronavirus coexistence with human beings in many countries. For example, the smallpox virus, which once killed hundreds of millions of people in history, was eradicated globally by vaccination in the 1970s COVID-19. Among the many COVID-19 vaccines currently used, including inactivated vaccines and adenovirus vector vaccines, mRNA vaccines - a relatively new vaccine category, are widely used and accompanied by a lot of controversy. This article will start with COVID-19, the history of vaccines, the basic introduction of mRNA, and gradually uncover the mystery of mRNA vaccines. This paper introduces its advantages and disadvantages, expounds the main development directions of mRNA vaccines, and reveals that mRNA has great development space and opportunities. This technology has many advantages. Through more in-depth research experiments, it can be applied to more medical technologies to help humans overcome diseases.

Citation Download Citation

Chenyuan Ji "Research on the advantages and disadvantages and the challenges of mRNA vaccines: taking the COVID-19 mRNA vaccine as an example", Proc. SPIE 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023), 1278931 (7 September 2023); https://doi.org/10.1117/12.2692432

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
5 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Proteins

COVID 19

Diseases and disorders

Antibodies

Transportation

In vitro testing

Nucleic acids

Show All Keywords

Keywords/Phrases

Search In:

Publication Years